Published in AIDS Weekly, March 3rd, 1997
Longitudinal studies appear best suited to answer this question. A pilot study by a French research team provides intriguing baseline data and a glimpse into the future.
G. Gorochov of Pitie-Salpetriere Hospital, Paris, and colleagues studied T-cell repertoires in three groups of patients: four long-term non-progressors, three typical progressors, and eight additional patients studied before and during combination antiretroviral therapy.
They reported their preliminary findings...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.